Thoracoabdominal Gastrectomy and Distal 2/3 Esophageal Resection with wide Lymph Node Dissection for type II and III Adenocarcinoma at the Gastro-Esophageal Junction
ConclusionTHX-ABD can be performed with high rates of R0 resections and with low in-hospital mortality. Long-term survival rate was not better compared with less extensive surgical procedures.Graphical abstract
Source: The American Journal of Surgery - Category: Surgery Source Type: research
More News: Adenocarcinoma | Chemotherapy | Esophagus Cancer | Gastrectomy | Gastroenterology | Study | Surgery